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ABSTRACT 
Purpose: Hydrogen sulfide (H2S) has many beneficial biological properties, including the 
ability to promote vasodilation.  It has been shown to be released from stem cells and 
increased by hypoxia.  Therefore, H2S may be an important paracrine factor in stem cell 
mediated intestinal protection.  We hypothesized that hydrogen sulfide created through 
conventional pathways would be a critical component of stem cell mediated intestinal 
protection following ischemic injury. 
Methods: Human bone marrow derived mesenchymal stem cells (BMSCs) were transfected 
with negative control siRNA (Scramble), or with siRNA to CBS, MPST, or CTH.  
Knockdown was confirmed with PCR and hydrogen sulfide gas assessed with AzMC 
fluorophore.  Eight week old male mice then underwent intestinal ischemia for 60 mins, after 
which time, perfusion was restored.  BMSCs from each of the above groups were then placed 
into the mouse abdominal cavity prior to final closure.  After 24 hours, mice were 
reanesthetized and mesenteric perfusion was assessed by Laser Doppler Imaging (LDI).  
Animals were then sacrificed and intestines excised, placed in formalin, paraffin embedded, 
and stained with H & E.  Intestines were then scored with a common mucosal injury grading 
scale. 
Results: PCR confirmed knockdown of conventional H2S producing enzymes (CBS, MPST, 
CTH).  Hydrogen sulfide gas was decreased in MPST and CTH transfected cells in normoxic 
conditions but was not decreased compared to scramble in any of the transfected groups in 
hypoxic conditions.  BMSCs promoted increased mesenteric perfusion at 24 hours post-
ischemia compared to vehicle.  Transfected stem cells provided equivalent protection.  
Histologic injury was improved with BMSCs compared to vehicle.  CBS, MPST, and CTH 
knockdown cell lines did not have any worse histological injury compared to Scramble.  
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Conclusion:   
Knocking down conventional H2S producing enzymes only impacted gas production in 
normoxic conditions.  When cells were transfected in hypoxic conditions, as would be 
expected in the ischemic intestines, hydrogen sulfide gas was not depressed.  These data, 
along with unchanged perfusion and histological injury parameters with conventional enzyme 
knockdown would indicate that alternative H2S production pathways may be initiated during 
hypoxic and/or ischemic events.   
 
KEY WORDS 
hydrogen sulfide, bone marrow-derived mesenchymal stromal cells, intestinal ischemia, 
perfusion, inflammation, small interfering RNA  
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INTRODUCTION 
Intestinal ischemia occurs when the mesenteric vasculature becomes acutely 
occluded.  Interrupted blood flow to the intestine leads to cellular damage, bowel necrosis, 
and mortality rates as high as 55-80% (1, 2).  Surviving patients who have undergone 
extensive intestinal resection may require intestinal transplantation or intravenous nutrition 
secondary to the inability to absorb appropriate enteral substrates.  Medical therapies to 
counteract the ischemic damage to the intestines are suboptimal, and therefore, novel 
treatments are desperately needed.  
In this regard, stem cell therapy may provide a promising treatment alternative to 
traditional medications.  Stem cells have been utilized for the experimental treatment of 
several ischemic conditions, including myocardial infarction and stroke (3, 4) .  Our group 
has previously appreciated that human bone marrow derived mesenchymal stem cells 
(BMSCs) can also increase survival following intestinal ischemia (5).  Improved survival was 
also linked with improved mesenteric perfusion, less mucosal injury, and altered 
inflammatory cytokines. 
It is likely that stem cells provide protection via the release of paracrine mediators (6).  
Hydrogen sulfide (H2S), long considered a toxic gas, has received considerable attention of 
late as an autocrine and paracrine mediator of a variety of physiological functions including 
cytoprotection, vasodilation and as a stimulus for angiogenesis (7-12).  Cellular H2S 
production is also increased by hypoxia (13, 14) which would promote autocrine and 
paracrine signaling (15).  This not only makes H2S metabolism an attractive candidate for 
oxygen sensing (16), but it also suggests that the hypoxic environment of ischemic intestinal 
tissue would increase H2S production by incipient stem cells, thereby triggering a number of 
intracellular cascades to promote adaptation to low oxygen environments.  This increase in 
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H2S would also help protect and sustain the stem cells themselves, which has previously been 
demonstrated (17-19). 
Hydrogen sulfide gas is produced through both conventional and unconventional 
pathways.  The conventional, and more often studied pathways, include three different 
parallel enzyme systems: cystathionine-β-synthase (CBS), cystathionine lyase (CSE) and 3-
mercaptopyruvate sulfurtransferase (MPST) (20) (Figure 1).  CBS is generally considered to 
be the predominant enzyme in the brain, CSE in the heart and vasculature, and MPST in the 
endothelium, vascular smooth muscle, and the brain (21).  Due to the difficulties in 
measuring H2S gas directly in biological systems, these three enzymes have been accepted as 
markers of cellular production of H2S (20, 22).   
It is unknown if hydrogen sulfide is a vital paracrine factor in stem cell mediated 
intestinal protection or if the conventional H2S producing enzymes play a role in this 
protection.  We therefore hypothesized that hydrogen sulfide gas produced via conventional 
pathways would be a critical paracrine factor in stem cell mediated intestinal protection 
following intestinal ischemia and reperfusion (I/R) injury.   
MATERIALS AND METHODS 
Cell Culture 
 
Human BMSCs were obtained from Dr. Darwin Prokop’s NIH funded lab at Texas 
A&M University where they procure, purify, and verify BMSCs from human subjects. 
BMSCs were reported to meet MSC defining criteria (23). BMSCs were cultured in 
MesenPRO RS™ Basal Medium for mesenchymal stem cells (Life Technologies, Grand 
Island, NY) with MesenPro RS™ Growth Supplement. Cells were cultured in 225 cm2 
polystyrene culture flasks at 37˚C in a humidified atmosphere of 5% CO2 in air. Once cells 
reached 90% confluency they were lifted from the flask with TrypLE Express (Life 
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Technologies), and passaged to expand primary cultures or used in experimentation.  BMSCs 
were used between passages 4-8.  A fluorescent automated cell counter was used to count 
cells (Luna™ Automated Cell Counter, Logos Biosystems Inc., Annandale, VA).  
 
Transfection Method with RNA Interference 
For siRNA transfection protocol, BMSCs were cultured to 90% confluency. Once 
cells were confluent they were lifted from flasks with TrypLE Express and counted using our 
automated cell counter. Cells (~2.25 million) were then plated onto a 225 cm2 polystyrene 
culture flask and incubated at 37˚C with 5% CO2 overnight. The next day, cells were then 
transfected for 24 hours in serum-free media with siRNA against CBS (Dharmacon™ human 
CBS ON-TARGETplus SMARTpool #L-008617-00), CTH (Dharmacon™ human CTH ON-
TARGETplus SMARTpool #L-003481-00), MPST (Dharmacon™ human MPST ON-
TARGETplus SMARTpool #L-010119-00), or scrambled sequences (Dharmacon™ ON-
TARGETplus Control Pool #D-001810-10-20) using a lipofectamine based transfection 
reagent (Dharmacon™ Dharmafect™ 1 Transfection Reagent #T-2001-02, Gene Expression 
and Gene Editing, GE Healthcare, Lafayette, CO, USA) per manufacturer’s instructions. The 
cells were incubated for an additional 24 hours in normal growth conditions and were 
subsequently used for animal experimentation. Knockdown of mRNA was confirmed by RT-
PCR with band intensities compared to the housekeeping gene, glyceraldehyde-3-phosphate 
dehydrogenase.   Primer sequences are listed in Table 1.   
In vitro H2S relative quantification 
 Cells were plated at a density of 10,000 cells per well in 96-well plates with gas-
permeable bottoms (Coy Laboratory Products Inc., Grass Lake, MI) and grown to 80-95% 
confluency.  The cells were then transfected and treated with the H2S-specific fluorophore 7-
azido-3-methylcoumarin (AzMC, 25 uM: λex=365nm and λem=450nm; Millipore Sigma, St. 
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Louis, MO).  AzMC is an irreversible fluorophore that provides a cumulative index of H2S 
production.  Fluorescence was measured on a SpectraMax M5e plate reader (Molecular 
Devices, Sunnyvale, CA) according to manufacturer’s recommendations and the cells were 
then placed in normoxia (21% O2, 5% CO2, and N2 balance) or hypoxia (5% O2, 5% CO2, and 
N2 balance) to mimic in vivo conditions for up to 24 hours in a model 856 HYPO hypoxia 
chamber (Plas Labs, Inc., Lansing, MI) at 37C.  The plates were removed at timed intervals, 
and fluorescence was measured before returning the plates to back to the culture incubator.  
Baseline H2S concentrations were subtracted from final concentrations and normalized to 
non-transfected control BMSCs.  Experiments were repeated three times (Total N=40/group) 
and data are presented as folds of control.  
Murine Intestinal I/R Model 
Experimental protocols and animal use were approved by the Indiana University 
Institutional Animal Care and Use Committee. Wild-type adult male mice (C57BL/6J, 
Stock No: 00664, 8-12 weeks; Jackson Laboratory, Bar Harbor, ME) underwent at least 48 
hours of acclimation to the new environment prior to experimentation. Murine animals were 
provided normal chow and water and kept in 12 light/12 dark cycle housing.  
 Mice were anesthetized using 3% isoflurane followed by maintenance at 1.5% 
isoflurane in oxygen. A heating pad was used to achieve temperature homeostasis and the 
abdomen was prepped using a hair removal lotion followed by sterile preparation with 70% 
ethanol and betadine. To account for intra-operative fluid losses, one milliliter of 0.9% 
normal saline was injected subcutaneously pre-operatively. All animals were given 
analgesia (1mg/kg buprenorphine and 5mg/kg carprofen) by subcutaneous injection pre-
operatively.   
 Under sterile conditions, a midline laparotomy was performed and the intestines 
were eviscerated. The base of the superior mesenteric artery was identified and clamped 
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using an atraumatic microvascular clamp as we have previously described (24). The 
intestines were then placed back into the abdominal cavity and the abdomen was 
temporarily closed using silk suture to prevent evaporative losses. Following 60 minutes of 
intestinal ischemia, the abdomen was reopened and the atraumatic clamp was removed. The 
abdominal fascia and skin were then closed in a two-layer fashion with silk suture. Prior to 
complete abdominal closure the animals underwent intraperitoneal injection with 250µL of 
phosphate buffered saline (PBS; vehicle control) or 2 million BMSCs suspended in 250µL 
of PBS from one of the following treatment groups: 1) BMSCs, 2) BMSCs transfected with 
negative control siRNA (Scramble), 3) BMSCs transfected with CBS siRNA, 4) BMSCs 
transfected with MPST siRNA, or 5) BMSCs transfected with CTH siRNA. Antibiotic 
ointment was applied to the abdominal incision following complete closure. Following 
surgery, animals were placed in a cage on a heating pad and allowed to awaken. Once fully 
recovered, animals were returned to animal housing. A single surgeon (ARJ) performed the 
abdominal surgeries, perfusion analysis, and stem cell infusions in all animals. 
Perfusion Analysis  
Perfusion was analyzed using a Laser Doppler perfusion Imager (LDI; Moor 
Instruments, Wilmington, DE) as previously described (24). Images were acquired at 
baseline, at the initial clamping of the superior mesenteric artery, and 24 hours after 
recovery. A region of interest was created around the entirety of exposed intestines to obtain 
a flux mean perfusion within this region.  Three images were acquired at each time point 
and averaged.  Perfusion data was expressed as a percentage of baseline (mean ± 
SEM)(N=8/group).  After the 24 hour recovery analysis, animals were euthanized with 
isoflurane overdose and cervical dislocation, and intestinal tissues were explanted for 
further analysis.  
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Histology Injury Score 
Intestinal tissues were harvested following euthanasia of experimental groups. 
Terminal ileums were then explanted and fixed using 4% paraformaldehyde with subsequent 
dehydration in 70% ethanol. Intestines were paraffin-embedded, sectioned, and subsequently 
stained with hematoxylin and eosin. A histological scoring method of intestinal damage was 
used as previously described: 0, no damage; 1, subepithelial space at the villous tip; 2, loss of 
mucosal lining at the villous tip; 3, loss of less than half of the villous structure; 4, loss of 
more than half of the villous structure; and 5, transmural necrosis (25) (26). All histological 
sections were evaluated by two blinded authors (ARJ, NAD) and scores were averaged (N=7-
8/group, total 14-16 scores).  Data were not normally distributed and are expressed as median 
and interquartile range. 
 
Statistical Analysis  
All statistical analysis was done using GraphPad Prism 7 (GraphPad Software, La 
Jolla, CA). Normalcy of data was assessed by the Shapiro Wilk and KS normality tests.  
Student’s t tests or the Mann-Whitney U test were used to compare groups.  P-values less 
than 0.05 were considered statistically significant.  
 
RESULTS 
siRNA Transfection and its effects on H2S production 
 In normoxic conditions, transfection of CBS, MPST, and CTH siRNAs effectively 
decreased mRNA levels of these enzymes (Figure 2A).  When H2S gas was measured, 
significant knockdown in gas production was seen with MPST and CTH transfection, but not 
with CBS (Figure 2B).  
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In an attempt to mimic the in vivo ischemic environment during in vitro transfection, 
separate groups of BMSCs were cultured in hypoxia.  In these conditions, there was still 
appropriate knockdown of CBS, MPST, and CTH mRNA with siRNA transfection (Figure 
3A), but the amount of H2S gas was no longer depressed in the conventional enzyme 
knockdown groups compared to Scramble (Figure 3B).  These results may suggest activation 
of alternative pathways for H2S production during hypoxia.   
 
Mesenteric Perfusion  
With use of LDI, intestinal perfusion was obtained at 24 hours following IR injury. 
Vehicle treated animals had significantly lower perfusion levels (26.4%±5.3) compared to 
BMSCs (72.4%±9.3, p=0.0006) and Scramble siRNA BMSCs (50.7%±8.0, p=0.01 Figure 
4A). There was no difference in perfusion between BMSC treated animals and Scramble 
siRNA BMSC treated animals (p=0.1605).  
In animals treated with BMSCs with siRNA knockdown of conventional H2S 
enzymes, a depression in perfusion following treatment was not observed compared to 
Scramble (Figure 4B). Perfusion at 24 hours in these animals were as follows: 1) CBS siRNA 
knockdown animals - 50.1% ± 6.1%, 2) CTH siRNA knockdown animals - 44.7% ± 6.9%, 
and 3) MPST siRNA knockdown animals - 47.2% ± 3.9%.   
 
Histological Injury 
 Intestinal mucosal injury scores were noted to be significantly improved in BMSC (1 
(IQR 1) and Scramble siRNA BMSC (2 (IQR 1.75)) groups compared to Vehicle (4 (IQR 3)) 
(Figure 5A).  Histology in the Scramble siRNA BMSC group was equivalent to the 
nontransfected BMSC treated animals.  When compared to the Scramble siRNA group, CBS, 
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MPST, or CTH knockdown cells did not result in significantly worse histological injury 
scores (Figure 5B).   
 
DISCUSSION 
Hydrogen sulfide gas has recently been proposed as a potent gasotransmitter that may 
be responsible for the protection of ischemic tissues (17, 27-29).  H2S has been observed to 
act like a free radical scavenger, to protect against cellular apoptosis, and to promote 
vasodilation (30).  Therefore, the paracrine release of H2S from stem cells may be a plausable 
mechanism of action for BMSCs to promote end organ protection following injury. H2S is 
endogenously secreted by BMSCs, and therefore, may also serve as a key paracrine 
gasotransmitter in stem cell mediated intestinal protection (31). 
Herein we discovered that hydrogen sulfide gas was reduced when conventional H2S 
producing enzymes were knocked down during normoxic conditions, but when cells were 
transfected and then cultured in hypoxia, gas levels were no different between transfected 
groups.  It is known that hypoxia stimulates hydrogen sulfide gas production (32).  Under 
normoxic conditions, CBS and CSE are usually found in the cytosol, while MPST is present 
in both the cytosol and in the mitochondria.  However, during hypoxia, CBS and CTH are 
transported to the mitochondria where they can increase H2S production in a matter of 
minutes due to significantly increased levels of cysteine (16). Additionally, H2S producing 
enzymes are distributed differently in different cells and tissues (21).  Therefore, the 
observation that H2S was not decreased with CBS knockdown (in spite of adequate mRNA 
knockdown) might suggest that CBS does not play as crucial of a role in hydrogen sulfide 
production in stem cells as the other two enzymes.  In our study, we did not observe a 
compensatory increase in the other two conventional enzyme’s mRNA when the third 
enzyme was knocked down.  Higher levels of H2S gas in hypoxia in the absence of a 
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compensatory increase in the other mRNAs would suggest that the increased gas was due to 
the activation of unconventional pathways of hydrogen sulfide production (Figure 1).   
This concept was also supported in the perfusion and histological data.  In the 
perfusion studies, all of the stem cell groups that underwent transfection provided equivalent 
protection following intestinal I/R.  All these groups had better post-ischemic mesenteric 
perfusion compared to vehicle, and the CBS, MPST, and CTH knockdown groups had 
equivalent protection to Scramble.  When the intestinal tissue was analyzed for histological 
injury, both non-transfected BMSC and Scramble BMSC transfected groups had better 
histological injury scores compared to vehicle.  However, CBS, MPST, and CTH knockdown 
groups were not any worse compared to Scramble groups.   
There are other methods of hydrogen sulfide production that have been described that 
are outside the scope of the three main conventional enzymes of CBS, MPST, and CTH (21).  
One such unconventional enzyme, catalase, was found to dependently generate H2S from 
dithiothreitol in both normoxia and hypoxia, concomitantly oxidizing H2S in the presence of 
oxygen. Catalase has also been shown to generate H2S from garlic oil, diallyltrisulfide, 
thioredoxin and sulfur dioxide, but not from sulfite, metabisulfite, carbonyl sulfide, cysteine, 
cystine, glutathione or oxidized glutathione (33). Other unconventional sources of hydrogen 
sulfide production include acid labile sulfides, mitochondrial complex I, thiosulfates, and 
volatile organic sulfides (21).  
The culmination of our data might suggest that hydrogen sulfide is not an important 
paracrine factor in stem cell mediated intestinal protection following ischemia.  However, 
knowing that application of exogenous hydrogen sulfide has elicited protection after 
intestinal injury (34, 35), that hydrogen sulfide is an important component of stem cell 
mediated intestinal protection in models of necrotizing enterocolitis (36), that multiple 
avenues of production exist (21), that it is nearly impossible to block all aspects of 
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production, and that it is a sensor for hypoxia (16), would all lead us to consider an 
alternative hypothesis. We would postulate that the reason we see similar protective effects 
when nontransfected stem cells or stem cells with knockdown of H2S producing enzymes are 
used is that hydrogen sulfide gas production is increased during ischemia via unconventional 
methods within the hypoxic environment.  It is likely these mechanisms of H2S gas 
production that drive stem cell mediated intestinal protection.  
 
LIMITATIONS 
 The superior mesenteric artery (SMA) ligation model of intestinal I/R does not model 
clinical intestinal ischemia to its fullest.  Although complete small bowel ischemia is possible 
secondary to SMA thrombus or embolus, the majority of intestinal ischemic episodes are due 
to segmental intestinal ischemia, such as may be seen with adhesive bowel obstructions or 
incarcerated hernias.  Nonetheless, this model mimics the most severe form of intestinal 
ischemia, and therefore, is likely considered the best animal model available to test the 
effectiveness of novel therapies.   
 An additional limitation is that we did not combine all three H2S producing enzymes 
together in an attempt to simultaneously knockdown all enzymes.  This would have required 
using 1/3 the dose of siRNA for each enzyme in order to match the total siRNA amount in the 
negative control Scramble group.  This would have resulted in less siRNA for each enzyme 
being used than what was used in the single knockdown groups.  We could also have used a 
second negative control (Scramble) in which we used three times the amount of Sramble 
siRNA and then used a triple knockdown in which each component would have matched their 
single knockdown counterpart, but we felt that this would have been too toxic to cells. 
 Furthermore, human cells were utilized in this study as a preclinical assessment in a 
mouse model of intestinal I/R injury.  Cross species transplantation usually results in acute 
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rejection and largely does not elicit effective results within immunocompetent hosts.  
However, mesenchymal stem cells, including those derived from bone marrow, have specific 
immunomodulatory properties that suppress T-lymphocyte proliferation and allow them to be 
transplanted across species (37, 38).   
 Finally, other cytokines and cell populations within the in vivo environment that are 
absent within the in vitro environment likely interact and affect the transplanted stem cells.  
The exact interactions and effects on the stem cells from these other factors are difficult to 
predict and may play a role in the study outcomes.  .   
 
CONCLUSION 
 BMSCs have been shown to be protective to the intestines in many studies.  
Furthermore, it is likely that stem cells provide protection through the release of one, or likely 
multiple, paracrine mediators.  This study suggests that either stem cells do not utilize 
hydrogen sulfide as a key paracrine mediator in intestinal protection, or more likely, that 
there are multiple avenues to generate hydrogen sulfide that have the ability to compensate 
for the more traditionally studied H2S producing enzymes when they are blocked or knocked 
down. 
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